Autologous bone marrow stem cell transplantation in patients with liver failure: A meta-analytic review

Stem Cells and Development

Volumn 24, Issue 2, 2015, Pages 147-159

  Wang, Kewei ^a   Chen, Xiaopan ^a   Ren, Jinma ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; CHOLESTEROL; GLUCOSE;

ASCITES; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CLOTTING; CHILD PUGH SCORE; CHOLESTEROL BLOOD LEVEL; FATIGUE; HUMAN; KIDNEY FUNCTION; LIVER FAILURE; LIVER FUNCTION; LIVER WEIGHT; LOSS OF APPETITE; META ANALYSIS; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; AUTOGRAFT; BIOLOGICAL MODEL; BONE MARROW TRANSPLANTATION; MEDLINE; METABOLISM; PATHOLOGY; TIME;

AUTOGRAFTS; BONE MARROW TRANSPLANTATION; HUMANS; LIVER FAILURE; MODELS, BIOLOGICAL; PUBMED; TIME FACTORS;

EID: 84920803927     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0337     Document Type: Review

References (64)

1. Blachier M, H Leleu, M Peck-Radosavljevic, DC Valla and F Roudot-Thoraval. (2013). The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58:593-608.
2. Sarin SK, A Kumar, JA Almeida, YK Chawla, ST Fan, H Garg, HJ de Silva, SS Hamid, R Jalan, et al. (2009). Acuteon-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 3:269-282.
3. Roychowdhury S, MR McMullen, SG Pisano, X Liu and LE Nagy. (2013). Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 57:1773-1783.
4. Dongiovanni P, QM Anstee and L Valenti. (2013). Genetic predisposition in NAFLD and NASH: Impact on severity of liver disease and response to treatment. Curr Pharm Des 19:5219-5238.
5. Shuh M, H Bohorquez, GE Loss Jr. and AJ Cohen. (2013). Tumor necrosis factor-alpha: life and death of hepatocytes during liver ischemia/reperfusion injury. Ochsner J 13:119-130.
6. Sanz-Garcia C, G Ferrer-Mayorga, Á González-Rodŕguez, AM Valverde, A Martń-Duce, JP Velasco-Martń, J Regadera, M Fernández and S Alemany. (2013). Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2. J Bio Chem 288:15342-15351.
7. Bantel H and K Schulze-Osthoff. (2012). Mechanisms of cell death in acute liver failure. Front Phys 3:79.
8. Peng L, DY Xie, BL Lin, J Liu, HP Zhu, C Xie, YB Zheng and ZL Gao. (2011). Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 54:820-828.
9. Pai M, D Zacharoulis, MN Milicevic, S Helmy, LR Jiao, N Levicar, P Tait, M Scott, SB Marley, et al. (2008). Autologous infusion of expanded mobilized adult bone marrowderived CD34 + cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 103:1952-1958.
10. Shi M, Z Zhang, R Xu, H Lin, J Fu, Z Zou, A Zhang, J Shi, L Chen, et al. (2012). Human mesenchymal stem cell transfusion is safe and improves liver function in acute-onchronic liver failure patients. Stem Cells Transl Med 1:725-731.
11. Fitzpatrick E, RR Mitry and A Dhawan. (2009). Human hepatocyte transplantation: state of the art. J Intern Med 266:339-357.
12. Garg V, H Garg, A Khan, N Trehanpati, A Kumar, BC Sharma, P Sakhuja and SK Sarin. (2012). Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 142:505-512.
13. Chan G, A Taqi, P Marotta, M Levstik, V McAlister, W Wall and D Quan. (2009). Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl 15:1696-1702.
14. Houlihan DD and PN Newsome. (2008). Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 135:438-450.
15. Dai LJ, HY Li, LX Guan, G Ritchie and JX Zhou. (2009). The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res 2: 16-25.
16. Trebol Lopez J, T Georgiev Hristov, M Garcia-Arranz and D Garcia-Olmo. (2011). Stem cell therapy for digestive tract diseases: current state and future perspectives. Stem Cells Dev 20:1113-1129.
17. Shiota G and T Yasui. (2012). Progress in stem cell biology in regenerative medicine for liver disease. Hepatol Res 42:15-21.
18. Polson J and WM Lee. (2005). AASLD position paper: the management of acute liver failure. Hepatology 41:1179-1197.
19. Amer ME, SZ El-Sayed, WA El-Kheir, H Gabr, AA Gomaa, N El-Noomani and M Hegazy. (2011). Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol 23: 936-941.
20. Lyra AC, MB Soares, LF da Silva, EL Braga, SA Oliveira, MF Fortes, AG Silva, D Brustolim, B Genser, RR Dos Santos and LG Lyra. (2010). Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 22:33-42.
21. El-Ansary M, I Abdel-Aziz, S Mogawer, S Abdel-Hamid, O Hammam, S Teaema and M Wahdan. (2011). Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev 8:972-981.
22. Saito T, K Okumoto, H Haga, Y Nishise, R Ishii, C Sato, H Watanabe, A Okada, M Ikeda, et al. (2011). Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev 20:1503-1510.
23. Sun S, F Yang, W Zhao, B Yan, C Chen and X Xu. (2012). Clinical observation of hepatic stem cell transplantation on liver cirrhosis with refractory ascites by ultrasonic guided percutaneous portal vein puncture. (Zhong hua Lin Chuang Yi Shi Za Zhi) Chin J Clinicians (Electronic edition) 6:3185-3189.
24. Mao H, H Jin, C Huang, Y Tang and Y Xie. (2013). Autologous bone marrow mesenchymal tem cell transplantation can improve liver function of patients with decompensated cirrhosis caused by hepatitis B. (Zhong hua Lin Chuang Yi Shi Za Zhi) Chin J Clinicians (Electronic edition) 7:3289-3293.
25. Stuck AE, LZ Rubenstein and D Wieland. (1998). Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ 316:469-471.
26. Am Esch JS, M Schmelzle, G Fürst, SC Robson, A Krieg, C Duhme, RY Tustas, A Alexander, HM Klein, et al. (2012). Infusion of CD133 + bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study. Ann Surg 255: 79-85.
27. Kuo TK, SP Hung, CH Chuang, CT Chen, YR Shih, SC Fang, VW Yang and OK Lee. (2008). Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134:2111-2121.
28. Hong ZF, XJ Huang, ZY Yin, WX Zhao and XM Wang. (2009). Immunosuppressive function of bone marrow mesenchymal stem cells on acute rejection of liver allografts in rats. Transplant Proc 41:403-409.
29. Kim WH, K Matsumoto, K Bessho and T Nakamura. (2005). Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166:1017-1028.
30. Nasir GA, S Mohsin, M Khan, S Shams, G Ali, SN Khan and S Riazuddin. (2013). Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med 11:78.
31. Suh YG, JK Kim, JS Byun, HS Yi, YS Lee, HS Eun, SY Kim, KH Han, KS Lee, et al. (2012). CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology 56:1902-1912.
32. Hardjo M, M Miyazaki, M Sakaguchi, T Masaka, S Ibrahim, K Kataoka and NH Huh. (2009). Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplant 18:89-99.
33. Li T, J Zhu, K Ma, N Liu, K Feng, X Li, S Wang and P Bie. (2013). Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats. J Surg Res 184:1161-1173.
34. Sato Y, H Araki, J Kato, K Nakamura, Y Kawano, M Kobune, T Sato, K Miyanishi, T Takayama, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106:756-763.
35. Wang L, X Wang, JD Chiu, G van de Ven, WA Gaarde and LD Deleve. (2012). Hepatic vascular endothelial growth factor regulates recruitment of rat liver sinusoidal endothelial cell progenitor cells. Gastroenterology 143:1555-1563.
36. Vassilopoulos G, PR Wang and DW Russell. (2003). Transplanted bone marrow regenerates liver by cell fusion. Nature 422:901-904.
37. di Bonzo LV, I Ferrero, C Cravanzola, K Mareschi, D Rustichell, E Novo, F Sanavio, S Cannito, E Zamara, et al. (2008). Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 57:223-231.
38. Russo FP, MR Alison, BW Bigger, E Amofah, A Florou, F Amin, G Bou-Gharios, R Jeffery, JP Iredale and SJ Forbes. (2006). The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130:1807-1821.
39. Wu XZ and D Chen. (2006). Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21: 1093-1098.
40. He X, TC Tsang, BL Pipes, RJ Ablin and DT Harris. (2005). A stem cell fusion model of carcinogenesis. J Exp Ther Oncol 5:101-109.
41. Zaim M, S Karaman, G Cetin and S Isik. (2012). Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol 91:1175-1186.
42. Huang K, DH Zhou, SL Huang and SH Liang. (2005). Agerelated biological characteristics of human bone marrow mesenchymal stem cells from different age donors. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13:1049-1053.
43. ChoumerianouDM, G Martimianaki, E Stiakaki, L Kalmanti, M Kalmanti and H Dimitriou. (2010). Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults. Cytotherapy 12:881-887.
44. Mohamadnejad M, K Alimoghaddam, M Mohyeddin-Bonab, M Bagheri, M Bashtar, H Ghanaati, H Baharvand, A Ghavamzadeh and R Malekzadeh. (2007). Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iranian Med 10:459-466.
45. Mohamadnejad M, M Namiri, M Bagheri, SM Hashemi, H Ghanaati, N Zare Mehrjardi, S Kazemi Ashtiani, R Malekzadeh and H Baharvand. (2007). Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 13:3359-3363.
46. Gasbarrini A, GL Rapaccini, S Rutella, MA Zocco, P Tittoto, G Leone, P Pola, G Gasbarrini and C Di Campli. (2007). Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis 39:878-882.
47. Couto BG, RC Goldenberg, LM da Fonseca, J Thomas, B Gutfilen, CM Resende, F Azevedo, DR Mercante, AL Torres, et al. (2011). Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int 31:391-400.
48. Shi Y, J Su, AI Roberts, P Shou, AB Rabson and G Ren. (2012). How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136-143.
49. Garcia-Olmo D, D Herreros, I Pascual, JA Pascual, E Del-Valle, J Zorrilla, P De-La-Quintana, M Garcia-Arranz and M Pascual. (2009). Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79-86.
50. Guadalajara H, D Herreros, P De-La-Quintana, J Trebol, M Garcia-Arranz and D Garcia-Olmo. (2012). Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int J Colorectal Dis 27:595-600.
51. Amin MA, D Sabry, LA Rashed, WM Aref, MA el-Ghobary, MS Farhan, HA Fouad and YA Youssef. (2013). Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transplant 27:607-612.
52. Park CH, SH Bae, HY Kim, JK Kim, ES Jung, HJ Chun, MJ Song, SE Lee, SG Cho, et al. (2013). A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure. Cytotherapy 15:1571-1579.
53. Han Y, L Yan, G Han, X Zhou, L Hong, Z Yin, X Zhang, S Wang, J Wang, et al. (2008). Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy 10:390-396.
54. Han HS, KS Ahn, JY Cho, YS Yoon, CJ Yoon, KU Park, SK Min, HK Lee and KH Ryu. (2014). Autologous stem cell transplantation for expansion of remnant liver volume with extensive hepatectomy. Hepatogastroenterology 61:156-161.
55. Zhang Z, H Lin, M Shi, R Xu, J Fu, J Lv, L Chen, S Lv, Y Li, et al. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 27:112-120.
56. Kim JK, YN Park, JS Kim, MS Park, YH Paik, JY Seok, YE Chung, HO Kim, KS Kim, et al. (2010). Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 19:1237-1246.
57. Kharaziha P, PM Hellström, B Noorinayer, F Farzaneh, K Aghajani, F Jafari, M Telkabadi, A Atashi, M Honardoost, MR Zali and M Soleimani. (2009). Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 21:1199-1205.
58. Khan AA, N Parveen, VS Mahaboob, A Rajendraprasad, HR Ravindraprakash, J Venkateswarlu, SG Rao, ML Narusu, MN Khaja, et al. (2008). Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc 40:1140-1144.
59. Spahr L, JF Lambert, L Rubbia-Brandt, Y Chalandon, JL Frossard, E Giostra and A Hadengue. (2008). Granulocytecolony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 48:221-229.
60. Fürst G, J Schulte am Esch, LW Poll, SB Hosch, LB Fritz, M Klein, E Godehardt, A Krieg, B Wecker, et al. (2007). Portal vein embolization and autologous CD133 + bone marrow stem cells for liver regeneration: initial experience. Radiology 243:171-179.
61. Yan L, Y Han, J Wang, J Liu, L Hong and D Fan. (2007). Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol 82:949-954.
62. Gordon MY, N Levicar, M Pai, P Bachellier, I Dimarakis, F Al-Allaf, H M'Hamdi, T Thalji, JP Welsh, et al. (2006). Characterization and clinical application of human CD34 + stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24:1822-1830.
63. Terai S, T Ishikawa, K Omori, K Aoyama, Y Marumoto, Y Urata, Y Yokoyama, K Uchida, T Yamasaki, et al. (2006). Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 24:2292-2298.
64. Yannaki E, A Anagnostopoulos, D Kapetanos, A Xagorari, F Iordanidis, I Batsis, P Kaloyannidis, E Athanasiou, G Dourvas, G Kitis and A Fassas. (2006). Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 34:1583-1587.